Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024678747> ?p ?o ?g. }
- W2024678747 endingPage "1254" @default.
- W2024678747 startingPage "1246" @default.
- W2024678747 abstract "The most widely used protocol for the induction of experimental allergic airway inflammation in mice involves sensitization by intraperitoneal (i.p.) injections of the antigen ovalbumin (OVA) used in conjunction with the adjuvant aluminium hydroxide (alum). Although adjuvants are frequently used, there are questions regarding the necessity of alum for murine asthma studies due to the non-physiological nature of this chemical.The objective of this study was to compare experimental asthma phenotypes between adjuvant and adjuvant-free protocols of murine allergic airway inflammation in an attempt to develop a standardized alternative to adjuvant use.An adjuvant-free OVA model of experimental asthma was investigated in BALB/c mice using i.p. or subcutaneous (s.c.) sensitization routes. For the s.c. sensitization, beta-galactosidase (beta-gal) was also tested as an antigen. In addition, OVA adjuvant and adjuvant-free sensitization protocols were compared in BALB/c and C57BL/6 mice. Open-field testing was performed to assess the effect of alum on mouse behaviour.Comparison of adjuvant vs. adjuvant-free and i.p. vs. s.c. protocols revealed that both adjuvant use and route of antigen application significantly influenced OVA-specific antibody production. Comparison of adjuvant and adjuvant-free protocols in this study clearly demonstrated the non-requirement of alum for the induction of acute allergic airway inflammation, as both protocols induce a similar disease phenotype. BALB/c mice were significantly more susceptible than C57BL/6 mice to sensitization. Using the improved s.c. adjuvant-free protocol, it was demonstrated that alternative antigens such as beta-gal can also be utilized. Behavioural studies indicated severe distress in mice treated with alum.The OVA s.c. adjuvant-free protocol used in this study generates a phenotype comparable to the benchmark adjuvant protocol widely used in the literature. The adjuvant-free alternative avoids the added complication of non-physiological adjuvants that may interfere with asthma treatment or prevention strategies." @default.
- W2024678747 created "2016-06-24" @default.
- W2024678747 creator A5014755696 @default.
- W2024678747 creator A5026023988 @default.
- W2024678747 creator A5037115735 @default.
- W2024678747 creator A5051240779 @default.
- W2024678747 creator A5053003825 @default.
- W2024678747 creator A5056773141 @default.
- W2024678747 creator A5058177872 @default.
- W2024678747 creator A5072469553 @default.
- W2024678747 creator A5076400367 @default.
- W2024678747 date "2009-08-01" @default.
- W2024678747 modified "2023-10-15" @default.
- W2024678747 title "Comparison of adjuvant and adjuvant-free murine experimental asthma models" @default.
- W2024678747 cites W1506574814 @default.
- W2024678747 cites W1543572242 @default.
- W2024678747 cites W1919254458 @default.
- W2024678747 cites W1928224582 @default.
- W2024678747 cites W1979862574 @default.
- W2024678747 cites W1979991507 @default.
- W2024678747 cites W1990156671 @default.
- W2024678747 cites W2011543777 @default.
- W2024678747 cites W2013377406 @default.
- W2024678747 cites W2023389255 @default.
- W2024678747 cites W2042045439 @default.
- W2024678747 cites W2046443421 @default.
- W2024678747 cites W2074720474 @default.
- W2024678747 cites W2079893720 @default.
- W2024678747 cites W2082190774 @default.
- W2024678747 cites W2082941861 @default.
- W2024678747 cites W2083036575 @default.
- W2024678747 cites W2092157690 @default.
- W2024678747 cites W2096381182 @default.
- W2024678747 cites W2102345655 @default.
- W2024678747 cites W2106665066 @default.
- W2024678747 cites W2113246580 @default.
- W2024678747 cites W2118965097 @default.
- W2024678747 cites W2121161301 @default.
- W2024678747 cites W2122719100 @default.
- W2024678747 cites W2126384811 @default.
- W2024678747 cites W2134204376 @default.
- W2024678747 cites W2134626164 @default.
- W2024678747 cites W2138426887 @default.
- W2024678747 cites W2145464760 @default.
- W2024678747 cites W2146409607 @default.
- W2024678747 cites W2152390607 @default.
- W2024678747 cites W2154719091 @default.
- W2024678747 cites W2164852931 @default.
- W2024678747 cites W2170382285 @default.
- W2024678747 cites W2286420524 @default.
- W2024678747 doi "https://doi.org/10.1111/j.1365-2222.2009.03260.x" @default.
- W2024678747 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2728898" @default.
- W2024678747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19438585" @default.
- W2024678747 hasPublicationYear "2009" @default.
- W2024678747 type Work @default.
- W2024678747 sameAs 2024678747 @default.
- W2024678747 citedByCount "75" @default.
- W2024678747 countsByYear W20246787472012 @default.
- W2024678747 countsByYear W20246787472013 @default.
- W2024678747 countsByYear W20246787472014 @default.
- W2024678747 countsByYear W20246787472015 @default.
- W2024678747 countsByYear W20246787472016 @default.
- W2024678747 countsByYear W20246787472017 @default.
- W2024678747 countsByYear W20246787472018 @default.
- W2024678747 countsByYear W20246787472019 @default.
- W2024678747 countsByYear W20246787472020 @default.
- W2024678747 countsByYear W20246787472021 @default.
- W2024678747 countsByYear W20246787472022 @default.
- W2024678747 countsByYear W20246787472023 @default.
- W2024678747 crossrefType "journal-article" @default.
- W2024678747 hasAuthorship W2024678747A5014755696 @default.
- W2024678747 hasAuthorship W2024678747A5026023988 @default.
- W2024678747 hasAuthorship W2024678747A5037115735 @default.
- W2024678747 hasAuthorship W2024678747A5051240779 @default.
- W2024678747 hasAuthorship W2024678747A5053003825 @default.
- W2024678747 hasAuthorship W2024678747A5056773141 @default.
- W2024678747 hasAuthorship W2024678747A5058177872 @default.
- W2024678747 hasAuthorship W2024678747A5072469553 @default.
- W2024678747 hasAuthorship W2024678747A5076400367 @default.
- W2024678747 hasBestOaLocation W20246787471 @default.
- W2024678747 hasConcept C147483822 @default.
- W2024678747 hasConcept C178790620 @default.
- W2024678747 hasConcept C185592680 @default.
- W2024678747 hasConcept C203014093 @default.
- W2024678747 hasConcept C207480886 @default.
- W2024678747 hasConcept C2776217527 @default.
- W2024678747 hasConcept C2776946954 @default.
- W2024678747 hasConcept C2777863537 @default.
- W2024678747 hasConcept C2779351315 @default.
- W2024678747 hasConcept C2780924562 @default.
- W2024678747 hasConcept C71924100 @default.
- W2024678747 hasConceptScore W2024678747C147483822 @default.
- W2024678747 hasConceptScore W2024678747C178790620 @default.
- W2024678747 hasConceptScore W2024678747C185592680 @default.
- W2024678747 hasConceptScore W2024678747C203014093 @default.
- W2024678747 hasConceptScore W2024678747C207480886 @default.
- W2024678747 hasConceptScore W2024678747C2776217527 @default.
- W2024678747 hasConceptScore W2024678747C2776946954 @default.